JP2024170457A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024170457A5 JP2024170457A5 JP2024145040A JP2024145040A JP2024170457A5 JP 2024170457 A5 JP2024170457 A5 JP 2024170457A5 JP 2024145040 A JP2024145040 A JP 2024145040A JP 2024145040 A JP2024145040 A JP 2024145040A JP 2024170457 A5 JP2024170457 A5 JP 2024170457A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- following structure
- compound
- activity
- inflammatory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962848719P | 2019-05-16 | 2019-05-16 | |
| US201962848648P | 2019-05-16 | 2019-05-16 | |
| US62/848,719 | 2019-05-16 | ||
| US62/848,648 | 2019-05-16 | ||
| PCT/US2020/032784 WO2020232190A1 (en) | 2019-05-16 | 2020-05-14 | Protein kinase inhibitors and uses thereof for the treatment of diseases and conditions |
| JP2021568650A JP7546603B2 (ja) | 2019-05-16 | 2020-05-14 | タンパク質キナーゼ阻害剤ならびに疾患および状態の治療のためのその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021568650A Division JP7546603B2 (ja) | 2019-05-16 | 2020-05-14 | タンパク質キナーゼ阻害剤ならびに疾患および状態の治療のためのその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024170457A JP2024170457A (ja) | 2024-12-10 |
| JP2024170457A5 true JP2024170457A5 (cg-RX-API-DMAC7.html) | 2024-12-19 |
| JP7897681B2 JP7897681B2 (ja) | 2026-07-30 |
Family
ID=70919255
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021568650A Active JP7546603B2 (ja) | 2019-05-16 | 2020-05-14 | タンパク質キナーゼ阻害剤ならびに疾患および状態の治療のためのその使用 |
| JP2024145040A Active JP7897681B2 (ja) | 2019-05-16 | 2024-08-27 | タンパク質キナーゼ阻害剤ならびに疾患および状態の治療のためのその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021568650A Active JP7546603B2 (ja) | 2019-05-16 | 2020-05-14 | タンパク質キナーゼ阻害剤ならびに疾患および状態の治療のためのその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12516055B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4480485A3 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7546603B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020275304B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3137869A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020232190A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018213219A1 (en) * | 2017-05-15 | 2018-11-22 | University Of Houston System | Pyrido[2,3-d]pyrimidin-7ones and related compounds as inhibitors of protein kinases |
| CA3137869A1 (en) * | 2019-05-16 | 2020-11-19 | Gregory Cuny | Protein kinase inhibitors and uses thereof for the treatment of diseases and conditions |
| CN113072471B (zh) * | 2021-03-02 | 2022-09-16 | 四川美大康华康药业有限公司 | 一种利非司特中间体及其制备方法 |
| WO2024097805A1 (en) * | 2022-11-01 | 2024-05-10 | Trustees Of Tufts College | Mixed lineage kinase domain like pseudokinase (mlkl) activators |
| WO2024199388A1 (zh) * | 2023-03-29 | 2024-10-03 | 微境生物医药科技(上海)有限公司 | 作为myt1抑制剂的化合物 |
| CN121197168A (zh) * | 2025-11-20 | 2025-12-26 | 中山大学 | UH15-38在制备防治PEDV-PoRVA共感染药物中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL117923A (en) * | 1995-05-03 | 2000-06-01 | Warner Lambert Co | Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds |
| AU742999B2 (en) | 1997-08-20 | 2002-01-17 | Warner-Lambert Company | Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation |
| SK10772002A3 (sk) * | 2000-01-27 | 2004-01-08 | Warner-Lambert Company | Pyridopyrimidinónové deriváty na liečbu neurodegeneratívnych ochorení |
| WO2014031571A1 (en) | 2012-08-21 | 2014-02-27 | Icahn School Of Medicine At Mount Sinai | Treatment of viral infections |
| WO2015179436A1 (en) * | 2014-05-19 | 2015-11-26 | Sanford-Burnham Medical Research Institute | Inflammation therapy using mekk3 inhibitors or blocking peptides |
| WO2018213219A1 (en) * | 2017-05-15 | 2018-11-22 | University Of Houston System | Pyrido[2,3-d]pyrimidin-7ones and related compounds as inhibitors of protein kinases |
| CA3137869A1 (en) | 2019-05-16 | 2020-11-19 | Gregory Cuny | Protein kinase inhibitors and uses thereof for the treatment of diseases and conditions |
-
2020
- 2020-05-14 CA CA3137869A patent/CA3137869A1/en active Pending
- 2020-05-14 US US17/595,406 patent/US12516055B2/en active Active
- 2020-05-14 EP EP24191377.1A patent/EP4480485A3/en active Pending
- 2020-05-14 AU AU2020275304A patent/AU2020275304B2/en active Active
- 2020-05-14 EP EP20729566.8A patent/EP3968991B1/en active Active
- 2020-05-14 JP JP2021568650A patent/JP7546603B2/ja active Active
- 2020-05-14 WO PCT/US2020/032784 patent/WO2020232190A1/en not_active Ceased
-
2024
- 2024-08-27 JP JP2024145040A patent/JP7897681B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2659863B2 (ja) | B型肝炎の治療への1,3−オキサチオランヌクレオシドアナログの使用方法 | |
| RU2702109C1 (ru) | Комбинированная терапия для лечения инфекций вгв | |
| JP2024071370A5 (cg-RX-API-DMAC7.html) | ||
| RU2005107314A (ru) | Пиримидопроизводные, характеризующиеся антипролиферативной активностью | |
| RU2003110577A (ru) | Гетероциклические соединения, связывающиеся с хемокиновыми рецепторами | |
| SG159561A1 (en) | Thiazole compounds and methods of use | |
| MXPA05005379A (es) | Tioureas de arilo sustituidas y compuestos relacionados; inhibidores de duplicacion viral. | |
| JP2013010792A5 (cg-RX-API-DMAC7.html) | ||
| TW200600492A (en) | Substituted aryl acylthioureas and related compounds; inhibitors of viral replication | |
| JP2013525318A5 (cg-RX-API-DMAC7.html) | ||
| WO2005067900A3 (en) | Azabenzofuran substituted thioureas as inhibitors of viral replication | |
| JP2818299B2 (ja) | ウイルス感染の治療におけるジデオキシヌクレオシドアナローグの使用 | |
| JP2019510027A5 (cg-RX-API-DMAC7.html) | ||
| JP2022533182A5 (cg-RX-API-DMAC7.html) | ||
| JP2005508337A5 (cg-RX-API-DMAC7.html) | ||
| JPH0920659A5 (cg-RX-API-DMAC7.html) | ||
| RU2006130000A (ru) | Органические соединения | |
| RU2009102270A (ru) | Производные тиазолилмочевины в качестве ингибиторов фосфатидилинозитол-3-киназы | |
| JPWO2023095860A5 (cg-RX-API-DMAC7.html) | ||
| JP2005511535A5 (cg-RX-API-DMAC7.html) | ||
| US20210379058A1 (en) | Arylamide Compounds For Treatment And Prevention Of Viral Infections | |
| RU2008112181A (ru) | Применение конденсированных производных имидазола для лечения заболеваний, опосредованных рецептором ccr3 | |
| RU2018142381A (ru) | Фармацевтический препарат | |
| WO2005095345A3 (en) | Heteroaryl guanidines as inhibitors of viral replication | |
| JP2023517197A (ja) | 抗rnaウイルス薬およびその適用 |